LAMEA Endoscopic Retrograde Cholangiopancreatography Market

LAMEA Endoscopic Retrograde Cholangiopancreatography/ERCP Market Size, Share & Industry Trends Analysis Report By Procedure, By Product, By Endotherapy Devices Type, By End User, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-8695 Publication Date: May-2022 Number of Pages: 120
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market would witness Market growth of 15.0% CAGR during the forecast period (2022-2028).

The use of precut sphincterotomy incorporating sphincterotomy for cases with difficult biliary access must be done immediately to minimize this risk. For patients with severe conditions, Ogilvie syndrome is characterized by severe colon dilatation in the presence of any mechanical barrier.

The esophageal diverticula's position in the oesophagus is used to classify the condition. Zenker's diverticula are the most frequent source of esophageal diverticula. Endoscopic retrograde cholangiopancreatography (ERCP) is an important tool for hepatobiliary system diagnosis and treatment.

In terms of appearance and diagnostic precision, magnetic resonance cholangiopancreatography (MRCP) is a novel non-invasive modality that projects liquid in the biliary and pancreatic ducts in an axial or three-dimensional image format, comparable to radiographic methods seen with direct contrast endoscopic retrograde cholangiopancreatography (ERCP).

A large number of gallbladder procedures, an increase in pancreatic disorders in Brazil, and a growing geriatric population base are expected to drive growth in the regional Market over the coming years. Due to factors such as a large number of gallbladder surgeries in Saudi Arabia, the United Arab Emirates, and South Africa, as well as an increase in pancreatic diseases coupled with high healthcare expenditures in the Middle Eastern countries. Over the next several years, the endoscopic retrograde cholangiopancreatography devices Market will be driven by robust product pipeline activity.

As part of its economic portfolio, the UAE has invested a lot in the establishment of world-class medical facilities, with high treatment standards for UAE citizens as well as visitors from other nations, particularly from the Middle East and Africa, who come to the UAE on medical tourist visas. According to the World Health Organization, one-third of adults in the UAE are obese, and one out of every five persons has diabetes. As the prevalence of lifestyle diseases rises, these people would require higher-quality healthcare. To meet this demand, the government is emphasizing on strengthening healthcare infrastructure and this factor would increase the adoption of endoscopic devices across the region.

The Brazil Market dominated the LAMEA Endoscopic Retrograde Cholangiopancreatography Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $58.8 million by 2028. The Argentina Market is estimated to grow at a CAGR of 15.6% during (2022 - 2028). Additionally, The UAE Market would display a CAGR of 14.6% during (2022 - 2028).

Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Endoscopic Retrograde Cholangiopancreatography Market is Predict to reach $2.3 Billion by 2028, at a CAGR of 9.1%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.

Scope of the Study

Market Segments Covered in the Report:

By Procedure

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting & Dilation

By Product

  • Endotherapy Devices
    • Stents & Sphincterotomes
    • Catheters
    • Lithotripter
    • Cannulas
    • Forceps
    • Snares
    • Guiding Wires
    • Balloons
    • Others
  • Endoscopes
  • Visualization Systems
  • Energy Devices
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centres & Clinics
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Steris PLC
  • Johnson & Johnson
  • Braun Melsungen AG
  • ConMed Corporation
  • Medtronic PLC
  • Karl Storz SE & Co. KG
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo